Promising new eczema drug shows hope for teens
NCT ID NCT06277765
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 34 times
Summary
This study tested a new medicine called CM310 in 180 teenagers with moderate-to-severe eczema (atopic dermatitis). The goal was to see if it could clear skin and reduce itching better than a placebo. Results showed that more teens using CM310 had significant skin improvement by week 18.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.